TITLE

Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun

AUTHOR(S)
Stirling, R. G.; Chung, K. F.
PUB. DATE
October 1999
SOURCE
Thorax;Oct1999, p865
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877251

 

Related Articles

  • Montelukast.  // Reactions Weekly;6/6/2009, Issue 1255, p25 

    The article cites a study on the association between Churg-Strauss syndrome and montelukast, a leukotriene receptor antagonist.

  • Leukotriene receptor antagonists produce mixed results. Bowser, Andrew // Dermatology Times;Jul99, Vol. 20 Issue 7, p19 

    Describes the results produced by zafirlukast, a leukotriene receptor antagonist for the treatment of atopic dermatitis in New Orleans, Los Angeles. Caution on the prescription of zafirlukast; Advantages and disadvantage in repeated administration of zafirlukast; Manifestation of the...

  • Montelukast and eosinophilia.  // WHO Drug Information;1999, Vol. 13 Issue 1, p18 

    Reports that the U.S. Food and Drug Administration has approved the use of the selective leukotriene receptor antagonist, montelukast, for the prophylaxis and chronic treatment of asthma. Association of treatment with eosinophilia; Churg-Strauss syndrome; Vasculitis.

  • Leukotriene receptor antagonists and Churg-Strauss syndrome: cause, trigger or merely an association? Keogh, Karina A // Drug Safety;2007, Vol. 30 Issue 10, p837 

    Concern has been raised in the medical literature that the use of leukotriene receptor antagonists for the treatment of asthma may be associated with an increased incidence of Churg-Strauss syndrome, a rare small-vessel vasculitic syndrome. This review provides a critical appraisal of the...

  • Leukotriene receptor antagonist therapy and Churg—Strauss syndrome: culprit or innocent bystander? Beasley, Richard; Bibby, Susan; Weatherall, Mark // Thorax;Oct2008, Vol. 63 Issue 10, p847 

    The article discusses various reports published within the issue, including the use of different methodologies concerning Churg-Strauss syndrome (CSS) and leukotriene receptor antagonist (LTRA), and another by Nathanie and others on a systematic review of (CSS) cases in association with (LTRA).

  • Leukotriene Modifiers and Churg-Strauss Syndrome: Adverse Effect or Response to Corticosteroid Withdrawal? Wechsler, M.E.; Pauwels, R.; Drazen, J.M. // Drug Safety;Oct1999, Vol. 21 Issue 4, p241 

    Zafirlukast, montelukast and pranlukast are all cysteinyl leukotriene receptor antagonists that have recently been approved for the treatment of asthma. Within 6 months of zafirlukast being made available on the market, 8 patients who received the agent for moderate to severe asthma developed...

  • Montelukast and Churg-Strauss syndrome. Solans, R.; Bosch, J. A.; Selva, A.; Orriols, R.; Vilardell, M. // Thorax;Feb2002, Vol. 57 Issue 2, p183 

    Several cases of eosinophilic conditions including Churg- Strauss syndrome (CSS) hove recently been reported in asthmatic patients being treated with antileukotriene receptor antagonists. One patient with CSS who experienced clinical relapse after treatment with montelukast and two asthmatic...

  • Churg-Strauss syndrome associated with the leukotriene antagonist montelukast. Boccagni, C.; Tesser, F.; Mittino, D.; Terazzi, E.; Naidi, P.; Colombi, S.; Zoppis, E.; Monaco, F. // Neurological Sciences;Apr2004, Vol. 25 Issue 1, p21 

    Churg-Strauss syndrome (CSS) is a disseminated small vessel vasculitis characterized by late-onset asthma, upper airways disease, eosinophilia and late neurological manifestations such as peripheral neuropathy. Recently, several cases of CSS have been reported in patients treated with...

  • Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast. Shimbo, Junsuke; Onodera, Osamu; Tanaka, Keiko; Tsuji, Shoji // Clinical Rheumatology;Dec2005, Vol. 24 Issue 6, p661 

    The authors studied eight cases of Churg-Strauss syndrome (CSS) associated with the use of pranlukast, a common cysteinyl leukotriene receptor antagonist (LTRA) in Japan. The patients who received pranlukast showed significantly increased peripheral blood eosinophil count, neurological...

  • Churg-Strauss syndrome associated with montelukast. Mukhopadhyay, A.; Stanley, N. N. // Postgraduate Medical Journal;Jun2001, Vol. 77 Issue 908, p390 

    Churg-Strauss syndrome (CSS) has recently been reported in patients with asthma receiving leukotriene receptor antagonists (LTRA5). In this paper a case of CSS after treatment with montelukast is described. As in other LTRA treated cases, prior withdrawal of maintenance oral steroid may have...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics